These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relations between monophasic action potential duration and refractoriness after cardioversion of persistent atrial fibrillation: results in wash-out and amiodarone-treated patients. Pandozi C; Gentilucci G; Calò L; Castro A; Lamberti F; Loricchio ML; Santini L; Magris B; Bulava A; Peichl P; Santini M Ital Heart J; 2003 Apr; 4(4):257-63. PubMed ID: 12784779 [TBL] [Abstract][Full Text] [Related]
4. Effect of IKr blocker nifekalant on atrial action potential duration after successful internal cardioversion of chronic atrial fibrillation. Kofune T; Watanabe I; Okubo K; Okumura Y; Masaki R; Shindo A; Saito S Pacing Clin Electrophysiol; 2005 May; 28(5):391-6. PubMed ID: 15869670 [TBL] [Abstract][Full Text] [Related]
5. Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man. Spurrell P; Kamalvand K; Higson M; Sulke N Europace; 2004 May; 6(3):229-35. PubMed ID: 15121076 [TBL] [Abstract][Full Text] [Related]
6. [Electrophysiologic characteristics of the atrium during chronic atrial fibrillation in man]. Pandozi C; Bianconi L; Villani M; Castro A; Toscano S; Altamura G; Jesi AP; Auriti A; Gentilucci G; Magris B; Santini M G Ital Cardiol; 1997 Mar; 27(3):270-7. PubMed ID: 9244729 [TBL] [Abstract][Full Text] [Related]
7. Sick sinus syndrome with and without atrial fibrillation: atrial refractoriness and conduction characteristics. De Sisti A; Leclercq JF; Fiorello P; Di Lorenzo M; Manot S; Halimi F; Attuel P Cardiologia; 1999 Apr; 44(4):361-7. PubMed ID: 10371788 [TBL] [Abstract][Full Text] [Related]
9. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation. Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579 [TBL] [Abstract][Full Text] [Related]
10. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence. Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation. Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400 [TBL] [Abstract][Full Text] [Related]
12. Effects of successful cardioversion of persistent atrial fibrillation on right ventricular refractoriness and repolarization. Manios EG; Kallergis EM; Kanoupakis EM; Mavrakis HE; Mouloudi HK; Klapsinos NK; Vardas PE Europace; 2005 Jan; 7(1):34-9. PubMed ID: 15670965 [TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans. Rostock T; Steven D; Lutomsky B; Servatius H; Drewitz I; Klemm H; Müllerleile K; Ventura R; Meinertz T; Willems S J Am Coll Cardiol; 2008 Jun; 51(22):2153-60. PubMed ID: 18510963 [TBL] [Abstract][Full Text] [Related]
14. Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation; a manifestation of atrial electrical remodelling in humans? Fynn SP; Todd DM; Hobbs WJ; Armstrong KL; Garratt CJ Eur Heart J; 2001 Oct; 22(19):1822-34. PubMed ID: 11549305 [TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and effective refractory period of the pulmonary vein ostia. Adragão P; Santos KR; Aguiar C; Neves JP; Abecassis M; Cavaco D; Morgado F; Bernardo R; Bonhorst D; Queiroz e Melo J; Seabra-Gomes R Rev Port Cardiol; 2002 Oct; 21(10):1125-34. PubMed ID: 12522975 [TBL] [Abstract][Full Text] [Related]
16. [Atrial refractoriness and its dispersion in different physiopathologic conditions]. Michelucci A; Padeletti L; Molino Lova R; Fradella GA; Monizzi D; Franchi F G Ital Cardiol; 1982; 12(8):555-62. PubMed ID: 7169154 [TBL] [Abstract][Full Text] [Related]
17. [Left atrial posterior wall and pulmonary vein refractory periods are associated with atrial fibrillation inducibility in a swine model]. Fernández-Lozano I; Toquero-Ramos J; Escudero-Vela C; Castedo-Mejuto E; Escudier-Villa JM; Alonso-Pulpón L Rev Esp Cardiol; 2006 Jul; 59(7):653-61. PubMed ID: 16938207 [TBL] [Abstract][Full Text] [Related]
18. Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. Neuberger HR; Schotten U; Blaauw Y; Vollmann D; Eijsbouts S; van Hunnik A; Allessie M J Am Coll Cardiol; 2006 Feb; 47(3):644-53. PubMed ID: 16458150 [TBL] [Abstract][Full Text] [Related]
19. [Atrial electrophysiologic properties in paroxysmal atrial fibrillation. Study conducted with the stimulation of 5 atrial sites]. Padeletti L; Michelucci A; Giovannini T; Mezzani A; Monopoli A; Franchi F G Ital Cardiol; 1989 May; 19(5):411-6. PubMed ID: 2767374 [TBL] [Abstract][Full Text] [Related]
20. Difference between electrical remodelling after pulmonary veins and right atrium appendage pacing. Hafid KA; Xin HC; Xi W; Yan ZQ; Bo Y Europace; 2007 Aug; 9(8):608-12. PubMed ID: 17630393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]